市場紹介
腫瘍溶解性ウイルスは、がん細胞に有利に感染し、がん細胞を死滅させる独特のウイルスです。これらはがん免疫療法の一部として導入され、がん細胞を選択的に標的にして腫瘍溶解を実行することによって作用します。腫瘍溶解性ウイルスは、がん細胞を直接殺し、患者自身の抗腫瘍免疫反応を刺激することが知られています。最初の腫瘍溶解性ウイルス免疫療法は、2004 年にラトビアで皮膚黒色腫の治療のために承認されました。人間の活動によって起こる避けられない環境の変化は、非黒色腫皮膚がんを含む多くの皮膚悪性腫瘍の発生率の増加につながるさまざまな要因を引き起こしています。皮膚黒色腫を含むさまざまながんの治療のための従来の放射線療法と化学療法には、治療指数が限られており、治療に関連した一連の副作用があります。米国 FDA が最初に承認した腫瘍溶解性ヘルペス ウイルス (改変単純ヘルペス ウイルス) は、手術不能な進行性黒色腫の治療薬として 2015 年に承認された薬剤タリモジーン ラヘルパレプベク (OncoVex、T-VEC) です。市場のダイナミクス
がんの発生率の増加と高度な治療オプションの採用の増加により、腫瘍溶解性ウイルス市場の需要が刺激されます。ただし、治療に関連したオフターゲット効果、副作用、薬剤耐性により、予測期間内の市場の成長が抑制される可能性があります。さらに、研究開発への巨額の投資、発展途上国における高齢者人口の増加とライフスタイルの変化により、予測期間中の市場の成長が促進されます。市場範囲
「2028年までの世界の腫瘍溶解性ウイルス市場分析」は、世界市場の傾向分析に特に焦点を当てた専門的で詳細な調査です。このレポートは、製品タイプ、アプリケーション、エンドユーザー、および地域ごとに詳細な市場分割を行い、腫瘍溶解性ウイルス市場の概要を提供することを目的としています。世界の腫瘍溶解性ウイルス市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、主要な腫瘍溶解性ウイルス市場プレーヤーの市場状況に関する重要な統計を提供し、市場の主要な傾向と機会を提供します。市場セグメンテーション
世界の腫瘍溶解性ウイルス市場は、製品タイプ、アプリケーション、エンドユーザーによって分割されています。製品タイプに基づいて、世界の腫瘍溶解性ウイルス市場は、HSVベースの腫瘍溶解性ウイルス、アデノウイルスベースの腫瘍溶解性ウイルス、ワクシニアウイルスベースの腫瘍溶解性ウイルス、水疱性口内炎ウイルスベースの腫瘍溶解性ウイルス、およびニューカッスル病ウイルスベースの腫瘍溶解性ウイルスに分類されます。アプリケーションに基づいて、世界の腫瘍溶解性ウイルス市場は、乳がん、肺がん、前立腺がん、黒色腫、脳腫瘍、血液がんなどに分類されます。腫瘍溶解性ウイルス市場は、エンドユーザーに基づいて、病院、専門クリニック、がん研究機関に分割されています。地域的枠組み
このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界の腫瘍溶解性ウイルス市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2019 年から 2028 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米。各地域ごとの腫瘍溶解性ウイルス市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、需要側と供給側の両方から腫瘍溶解性ウイルス市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、中南米は、これらの地域の腫瘍溶解性ウイルス市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。市場関係者
レポートは、有機的および無機的成長戦略として腫瘍溶解性ウイルス市場の主要な発展をカバーしています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。腫瘍溶解性ウイルス市場の市場プレーヤーは、世界市場での腫瘍溶解性ウイルスの需要の高まりに伴い、将来的に有利な成長機会が期待されています。以下に挙げるのは、腫瘍溶解性ウイルス市場に従事する数社のリストです。レポートには、SWOT分析と市場戦略とともに、主要な腫瘍溶解性ウイルス市場企業のプロフィールも含まれています。さらに、このレポートは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を含む業界の主要企業に焦点を当てています。- • アムジェン社 • Oncolytics Biotech, Inc. • メルク社 • トランスジーン • オンコリス バイオファーマ株式会社 • Targovax ASA • Vyriad Inc. • Genelux Corporation • ソレント セラピューティクス社 • Lokon Pharma AB
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Amgen Inc
2. Oncolytics Biotech, Inc.
3. Merck & Co., Inc.
4. Transgene
5. Oncolys BioPharma Inc.
6. Targovax ASA
7. Vyriad Inc.
8. Genelux Corporation
9. Sorrento Therapeutics, Inc.
10. Lokon Pharma AB
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)